Position statement of the German STI Society on the prophylactic use of doxycycline to prevent STIs (Doxy‐PEP, Doxy‐PrEP)
Authors:
- Ricardo Niklas WernerRWRicardo Niklas Werner
- For The German Sti Society (Dstig)F(For The German Sti Society (Dstig)
Open Access
- 20 December 2023
- journal article
- research article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 22 (3) , 466-478
Abstract
Summary: Over the past two decades, there has been a rise in the incidence of syphilis, particularly among men who have sex with men (MSM). This has sparked interest in studying the prophylactic use of doxycycline to prevent syphilis and other sexually transmitted infections (STIs), commonly referred to as Doxycycline Pre‐ or Post‐Exposure Prophylaxis (Doxy‐PrEP, Doxy‐PEP). At the same time, demand from potential users for this preventive measure is increasing.Several randomized controlled trials have demonstrated that the prophylactic use of doxycycline in MSM and trans women using HIV pre‐exposure prophylaxis (HIV‐PrEP) or living with an HIV infection effectively reduces the risk of syphilis and chlamydia infections. At present, however, unresolved questions remain, particularly regarding implications of a broad implementation of prophylactic doxycycline to prevent STIs on tetracycline and other antimicrobial resistance in bacterial STIs, non‐STI‐related bacterial pathogens, and the microbiome.In response to the increasing demand and the challenge of balancing effectiveness, safety, and the risk of promoting antibiotic resistance, the German STI Society (DSTIG) has issued a position statement, providing specific recommendations regarding potential indications, criteria, and occasions for the use of doxycycline in STI prevention. These recommendations are based on current evidence and expert opinion.Keywords
This publication has 28 references indexed in Scilit:
- Enhancing the Control of Syphilis Among Men Who Have Sex With Men by Focusing on Acute Infectious Primary Syphilis and Core Transmission GroupsSexually Transmitted Diseases, 2019
- Doxycycline use in MSM taking PrEPThe Lancet HIV, 2018
- Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trialThe Lancet Infectious Diseases, 2018
- European evidence‐based (S3) guideline for the treatment of acne – update 2016 – short versionJournal of the European Academy of Dermatology and Venereology, 2016
- Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trialThorax, 2015
- Doxycycline Prophylaxis to Reduce Incident Syphilis among HIV-Infected Men Who Have Sex With Men Who Continue to Engage in High-Risk SexSexually Transmitted Diseases, 2015
- Abnormal Weight Gain and Gut Microbiota Modifications Are Side Effects of Long-Term Doxycycline and Hydroxychloroquine TreatmentAntimicrobial Agents and Chemotherapy, 2014
- Australian sexually transmissible infection and HIV testing guidelines for asymptomatic men who have sex with men 2014: a review of the evidenceSexual Health, 2014
- Role of Doxycycline in Clostridium difficile Infection AcquisitionAnnals of Pharmacotherapy, 2014
- Chemoprophylaxis Is Likely to Be Acceptable and Could Mitigate Syphilis Epidemics Among Populations of Gay MenSexually Transmitted Diseases, 2011